Medicare Enrolled
Dr. Bolkar Sahinler, MD.
Interventional Pain Medicine Physician · Lubbock, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sahinler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sahinler?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sahinler
Dr. Bolkar Sahinler is an interventional pain medicine physician in Lubbock, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sahinler performed 4,583 Medicare services across 1,926 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sahinler received a total of $158,220 from 35 pharmaceutical and/or device companies across 522 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sahinler is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 19% volume in TX
$158,220 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,583
Medicare services
Top 19% in TX for interventional pain medicine physician
1,926
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~229 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging, lower concentration | 2,050 | $0 | $2 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
426 | $9 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
297 | $63 | $213 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
274 | $119 | $481 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
198 | $89 | $315 |
| Injection, methylprednisolone acetate, 40 mg | 160 | $6 | $19 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
159 | $200 | $1,008 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
142 | $55 | $354 |
| Spinal drug pump reprogramming and refill Electronic adjustment of the settings for a spinal drug infusion pump and replenishment of the medication reservoir. |
142 | $65 | $348 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
104 | $58 | $65 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
103 | $190 | $199 |
| Injection, fentanyl citrate, 0.1 mg | 96 | $1 | $3 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
94 | $0 | $5 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
59 | $66 | $963 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
57 | $86 | $275 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
31 | $170 | $718 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
24 | $33 | $149 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 22 | $64 | $445 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
18 | $200 | $1,075 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
18 | $109 | $532 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
17 | $192 | $972 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
17 | $102 | $493 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
17 | $39 | $168 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
14 | $84 | $765 |
| Spinal neurostimulator generator insertion Surgical placement of a spinal neurostimulator generator or receiver device. |
11 | $176 | $1,240 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
11 | $432 | $2,338 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
11 | $286 | $1,048 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
11 | $458 | $2,312 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$158,220
Total received (2018-2024)
Avg $22,603/year across 7 years
Top 1% in TX for interventional pain medicine physician
35
Companies
522
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$141,597 (89.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,623 (10.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$138,230
2023
$8,331
2022
$4,172
2021
$1,551
2020
$991
2019
$3,109
2018
$1,837
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$145,910
Medtronic USA, Inc.
$2,792
Abbott Laboratories
$2,628
Relievant Medsystems, Inc.
$1,771
Vertiflex, Inc.
$1,553
BOSTON SCIENTIFIC CORPORATION
$574
Collegium Pharmaceutical, Inc.
$462
Boston Scientific Corporation
$376
SI-BONE, INC.
$244
ABBVIE INC.
$205
MML US, Inc.
$189
PFIZER INC.
$175
AbbVie Inc.
$156
SI-BONE, Inc.
$146
SurGenTec
$139
DePuy Synthes Sales Inc.
$136
Canon Medical Systems USA, Inc.
$110
Allergan, Inc.
$107
Takeda Pharmaceuticals U.S.A., Inc.
$82
Assertio Therapeutics, Inc.
$54
Allergan Inc.
$53
Daiichi Sankyo Inc.
$51
Nevro Corp.
$51
Novartis Pharmaceuticals Corporation
$39
Teva Pharmaceuticals USA, Inc.
$35
Spinal Simplicity, LLC
$27
Zyla Life Sciences, Inc.
$22
VERTEX PHARMACEUTICALS INCORPORATED
$20
ARBOR PHARMACEUTICALS, INC.
$19
RedHill Biopharma Inc.
$18
Nalu Medical, Inc.
$16
Lilly USA, LLC
$16
Horizon Therapeutics plc
$15
Biohaven Pharmaceuticals, Inc.
$14
Lundbeck LLC
$13
Top 3 companies account for 95.6% of total payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · AIMOVIG · AJOVY · Accurian · Amitiza · BOTOX · BOTOX THERAPEUTIC · EMGALITY · ETERNA · Edarbi · Gralise · HA MINUTEMAN G3-R · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · LYRICA · MONOVISC · MYPTM · Morphabond ER · Movantik · NURTEC ODT · Nalu Neurostimulation System · OSTEOCOOL RF ABLATION · PEAK · PENNSAID · PROCLAIM · PRODIGY · QULIPTA · ReActiv8 · S-Series SCS Leads · SPRIX · SUPERION · SYNCHROMED · SYNCHROMEDII · Senza Spinal Cord Stimulation System · Superion · Superion ISS · Superion Indirect Decompression System · Swift-Lock SCS · TiLink · UBRELVY · VANTA ADAPTIVESTIM · VYEPTI · Vanta · XTAMPZA · XTAMPZAER · Xtampza ER · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 1% for interventional pain medicine physician in TX.
Equivalent to $3,452 per 100 Medicare services performed
Geographic Context
Interventional pain medicine physicians within 10 mi
6
Per 100K population
1.9
County median income
$63,367
Nearest hospital
COVENANT MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sahinler is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), with mixed engagement industry engagement in the top 1% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sahinler experienced with contrast dye for imaging, lower concentration?
Based on Medicare claims data, Dr. Sahinler performed 2,050 contrast dye for imaging, lower concentration services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sahinler receive payments from pharmaceutical companies?
Yes. Dr. Sahinler received a total of $158,220 from 35 companies across 522 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sahinler's costs compare to other interventional pain medicine physicians in Lubbock?
Dr. Sahinler's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sahinler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Lubbock
Browse interventional pain medicine physicians in Lubbock ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in TX
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in TX
Which TX interventional pain medicine physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology